glp-1 agonists cardiovascular diseases in Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies Mechanisms by which GLP-1 agonists

Food preferences also shift for many users

Additionally, obesity contributes to joint and musculoskeletal disorders 6 , mental health challenges 7 , and a heightened risk of various cancers 8

The best read of the bunch is from Annals of Internal Medicine: Accurate Measurements of Gastric Emptying and Gastrointestinal Symptoms in the Evaluation of Glucagon-like Peptide-1 Receptor Agonists GI Symptoms: In clinical trials of GLP-1 RAs, GI symptoms are usually evaluated solely by participant self-report, which is unreliable

In the tables below, the drugs are organized according to other factors that may be important in guiding treatment decisions

GLP-1 plays a key role in glucose control, weight loss, digestion, and cardiovascular protection

With their ability to control blood sugar levels, GLP-1s have also demonstrated positive impacts on weight loss and reduced cardiovascular risks